Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
startups
venture capital
5
×
boston blog main
national top stories
boston top stories
cancer
deals
new york blog main
san diego blog main
san diego top stories
san francisco blog main
avalon ventures
boston
clinical trials
correlation ventures
drugs
financing
funding
innovation
investing
laura shawver
medicxi
new york top stories
orbimed
ra capital management
san diego
synthetic biology
synthorx
vc
20/20 healthcare partners
acute myeloid leukemia
american society of clinical oncology
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
antisense oligonucleotide
applied therapeutics
What
drugs
5
×
new
advance
biology
cytokine
enhanced
neuro
san
suite
synthetic
synthorx
ahead
aims
asco
associated
backed
bio
biologic
branded
cause
ceo
choices
commissioner
companies
company
consumers
costly
counterweight
demonstrating
develop
device
dialysis
diego’s
disease
diseases
drug
elevatebio
enclear
epilepsy
fda
Language
unset
Current search:
xconomy.com
×
drugs
×
" venture capital "
×
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs
